2026-01-18 - Analysis Report
**Financial Report for International Business Machines Corp (IBM)**
===========================================================

### Quick Facts

* Company Overview: International Business Machines Corp is a multinational technology company.
* Recent Stock Price: $305.67
* 5-day Moving Average: $305.60
* 20-day Moving Average: $302.11
* 60-day Moving Average: $303.84

### Return Rate Comparison
--------------------------------

| Ticker | Cumulative Return |
| --- | --- |
| IBM | 130.94% |
| S&P 500 (VOO) | 93.36% |

The cumulative return of IBM is 37.58% higher than the S&P 500 (VOO).

### Alpha, Beta Analysis
-------------------------

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | -20.0% | 24.9% | -23.0% | 0.9 | 101.6B |
| 2017-2019 | -24.0% | 24.9% | -41.0% | 1.0 | 119.8B |
| 2018-2020 | -10.0% | 24.9% | -30.0% | 1.0 | 112.5B |
| 2019-2021 | 13.0% | 15.4% | -30.0% | 0.9 | 124.9B |
| 2020-2022 | -1.0% | 18.2% | 1.0% | 0.8 | 131.7B |
| 2021-2023 | 22.0% | 18.2% | 21.0% | 0.5 | 152.9B |
| 2022-2024 | 51.0% | 17.9% | 32.0% | 0.6 | 205.5B |
| 2023-2025 | 129.0% | 9.7% | 67.0% | 0.7 | 276.9B |

### Recent Stock Price Fluctuations
-----------------------------------

* 5-day SMA: $305.60
* 20-day SMA: $302.11
* 60-day SMA: $303.84

### RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence
-----------------------------------------------------------------

* Market Risk Indicator (MRI): 0.80
* RSI: 50.36
* PPO: 0.12
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium (MRI 0.80)
* Recent (20 days) relative divergence change: -3.60 (-)
* 7-day Rank change: 0 (0)
* 7-day Dynamic Expected Return change: 0.00 (0)
* Expected Return: -7.60% (compared to S&P 500 if invested long-term)

### Recent News & Significant Events
-------------------------------------

* [Multiple headlines from 2026-01-05 to 2026-01-17, including upgrades, price target resets, and good performance]

### Analyst Opinions
----------------------

* Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 2.38 (~Buy)
  - Opinions: 19
  - Target Price (avg/high/low): $302.05 / $375.00 / $198.00

### Recent Earnings Analysis
-----------------------------

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-23 | 1.87 | $16.33 B$ |
| 2025-07-24 | 2.36 | $16.98 B$ |
| 2025-04-24 | 1.14 | $14.54 B$ |
| 2024-10-30 | -0.36 | $14.97 B$ |

### Revenue and Profitability
---------------------------

| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | $16.33B | 57.31% |
| 2025-06-30 | $16.98B | 58.77% |
| 2025-03-31 | $14.54B | 55.23% |
| 2024-12-31 | $17.55B | 59.47% |
| 2024-09-30 | $14.97B | 56.26% |

### Capital and Profitability
---------------------------

| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | $27.91B | 6.25% |
| 2025-06-30 | $27.51B | 7.98% |
| 2025-03-31 | $26.88B | 3.92% |
| 2024-12-31 | $27.31B | 10.67% |
| 2024-09-30 | $24.45B | -1.35% |

### Comprehensive Analysis (Summary of previous items)
----------------------------------------------------

Overall, IBM has reported a strong performance in the recent quarter with a cumulative return of 130.94%, outperforming the S&P 500 (VOO) with a cumulative return of 93.36%. The company's beta has been relatively stable, ranging from 0.5 to 1.0 over the past few years. The recent stock price fluctuations show a slight upward trend, with a 5-day SMA of $305.60 and a 20-day SMA of $302.11. However, the Market Risk Indicator (MRI) suggests a medium risk level, and the expected return is negative (-7.60%). The analyst consensus is to buy the stock, with an average target price of $302.05. The recent earnings analysis shows a mixed performance, with a strong EPS of 2.36 in Q2 2025 but a negative EPS of -0.36 in Q4 2024. The revenue and profitability data show a consistent profit margin of around 57% in the recent quarter. Overall, the comprehensive analysis suggests that IBM is a stable company with a strong performance in the recent quarter, but with some concerns regarding the expected return and the medium risk level.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.